Jowi Tsidkenu Pili Cruz

Dr. Jowi Tsidkenu Pili Cruz

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
Herminiño LagunzadHerminiño Lagunzad
Herminiño Lagunzad
WPWarren B. Panizales
Warren B. Panizales
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
JNJose Jurel M. Nuevo
Jose Jurel M. Nuevo
Antimicrobial resistance and persistent biofilm-associated infections have renewed interest in bacteriophages as alternatives or complements to conventional antibiotics. However, broader therapeutic adoption remains constrained by slow phage discovery, incomplete genome characterization, narrow host range, complex therapeutic matching, and manufacturing variability. Artificial intelligence (AI) offers computational approaches that may help address several of these limitations. This comprehensive narrative review discusses current AI applications across the bacteriophage pipeline, including metagenomic phage discovery, genome annotation, phage–host interaction prediction, personalized phage selection, cocktail optimization, and phage–antibiotic combination design. The review also examines AI-assisted synthetic biology approaches, including receptor-binding protein redesign, CRISPR-enabled engineering, generative genome design, and biosafety screening, as well as emerging applications in bioprocess optimization, yield prediction, purification analytics, quality assurance, and supply-chain management. Current evidence suggests that AI may accelerate phage identification, improve host-range prediction, support therapeutic optimization, and strengthen manufacturing consistency, potentially facilitating the transition of phage therapy from individualized rescue interventions toward more scalable antimicrobial platforms. Nevertheless, major limitations remain, including fragmented, taxonomically biased datasets; limited external validation; restricted interpretability; privacy concerns; biosafety oversight; and evolving regulatory frameworks. Future progress will depend on standardized datasets, multimodal validation, scalable manufacturing systems, experimental and clinical verification, and coordinated regulatory development.

19 June 2026 in Biology
Verified
Journal Article
Open access
PDF file
COChristian Joseph Ong
Christian Joseph Ong
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
EREdison D. Ramos
Edison D. Ramos
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
JNJose Jurel M. Nuevo
Jose Jurel M. Nuevo
Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant multidrug-resistant pathogen, frequently associated with persistent infections and biofilm formation, underscoring the urgent need for alternative antimicrobial strategies. Bioactive compounds derived from fungi have attracted considerable attention due to their structural diversity and demonstrated antibacterial activity against MRSA. This study employed a scientometric approach to assess global research trends, thematic evolution, and collaborative networks concerning fungi-derived anti-MRSA compounds. Bibliographic data were collected from the Scopus database, and a total of 1666 English-language articles and reviews published up to 2025 were analyzed using Bibliometrix/Biblioshiny and VOSviewer. The findings indicate a marked increase in research output after 2010, reflecting heightened scientific interest in fungal natural products for MRSA management. China and the United States emerged as leading contributors in terms of publication volume and international collaboration. Thematic analysis revealed a shift from broad antimicrobial screening to more specialized investigations, including antibiofilm activity, secondary metabolites, endophytic fungi, molecular docking, and antimicrobial resistance. Nonetheless, several challenges persist, such as insufficient mechanistic validation, limited toxicity and pharmacokinetic assessments, and a lack of clinically relevant in vivo studies. Overall, the field is increasingly multidisciplinary, integrating microbiology, natural product chemistry, and computational methodologies to advance the discovery of anti-MRSA agents.

5 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ACAlyssa Camba
Alyssa Camba
RGRishi Denice S. Ganadin
Rishi Denice S. Ganadin
ASAmador F. Simando
Amador F. Simando
PYPaul K. Yu
Paul K. Yu
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
Post-spinal anesthesia hypotension during cesarean delivery poses significant risks to maternal cardiac output and fetal oxygenation. Although phenylephrine (PE) is the standard vasopressor, its use is linked to an increased incidence of maternal bradycardia. In contrast, norepinephrine (NE) offers a more favorable hemodynamic profile and is emerging as a promising alternative. This systematic review and meta-analysis of 18 randomized controlled trials compared NE and PE for the prevention and treatment of post-spinal hypotension in cesarean section parturients. Our findings demonstrate that while NE and PE are equally effective in managing hypotension, NE significantly reduces the incidence of maternal bradycardia (OR = 0.49 [CI: 0.38 to 0.62]) and shows a trend toward fewer adverse maternal events, such as dizziness and reactive hypertension. Additionally, neonatal outcomes indicated a lower birth weight with NE—although still within the normal range—along with tendencies toward lower umbilical arterial lactate levels and improved umbilical vein blood gas pH. These results support NE as a viable alternative to PE, particularly for lowering the incidence of maternal bradycardia, and provide crucial evidence for updating clinical practice guidelines to enhance maternal and neonatal care during cesarean deliveries. Systematic review registration ID: CRD42024593459 https://www.crd.york.ac.uk/PROSPERO/view/CRD42024593459

5 October 2026 in Discover Artificial Intelligence
Verified
Journal Article
Open access
PDF file
COChristian Joseph Ong
Christian Joseph Ong
RNRahmatullah Nazari
Rahmatullah Nazari
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
Antimicrobial resistance (AMR) is a complex One Health challenge driven by the interconnected emergence, selection, persistence, and dissemination of resistance across clinical, animal, agricultural, food, and environmental microbiomes. Resistome profiling through whole-genome and metagenomic sequencing has transformed surveillance by enabling comprehensive characterization of antimicrobial resistance genes (ARGs); however, conventional homology-based approaches remain constrained by incomplete reference databases and may overlook divergent or previously uncharacterized resistance determinants. This review critically examines how artificial intelligence (AI), including machine learning, deep learning, transformer architectures, and biological language models, is advancing resistome profiling through ARG detection and classification, prioritization of putative novel resistance determinants, antimicrobial resistance phenotype prediction, and inference of microbial host and mobile genetic element associations. Particular emphasis is placed on the conceptual distinction between detecting resistance-associated sequence features and forecasting the future emergence of AMR. Although AI can identify sequence patterns associated with resistance and integrate genomic, metagenomic, multi-omic, clinical, epidemiological, and environmental data to estimate risk, these predictions do not independently establish that a candidate determinant will confer resistance in a new host, undergo successful horizontal transfer, persist within microbial populations, or become selectively advantageous under future ecological or clinical conditions. Resistance emergence is contingent on gene expression, genomic background, host compatibility, mobility, fitness effects, selection pressure, ecological persistence, and epidemiological connectivity. Accordingly, current AI outputs should generally be interpreted as detection, prioritization, phenotype prediction, or risk estimation rather than definitive forecasts of future resistance emergence. Major translational barriers include database bias, phylogenetic confounding, model opacity, limited genotype–phenotype data, poor external generalizability, inconsistent metadata, and insufficient prospective and experimental validation. Future progress will require biologically interpretable models, harmonized longitudinal One Health datasets, explicit evidence grading, and prospective validation against predefined emergence outcomes to establish whether AI-derived early-warning signals provide reliable and actionable lead time for AMR surveillance.

10 September 2026 in Biology
Verified
Journal Article
Open access
PDF file
COChristian Joseph Ong
Christian Joseph Ong
Johnalie Nagal CabalbagJohnalie Nagal Cabalbag
Johnalie Nagal Cabalbag
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
Teodora ValderamaTeodora Valderama
Teodora Valderama
CRCelia Roble Roslin
Celia Roble Roslin
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
Southeast Asia faces a substantial burden of antimicrobial resistance (AMR), creating increasing interest in bacteriophage-based antimicrobial strategies. However, the regional development, contributors, collaboration patterns, and evolving research priorities of this field remain insufficiently characterized. This study conducted a bibliometric analysis of Scopus-indexed publications on bacteriophage-based antimicrobial research affiliated with Southeast Asian countries from 1981 to 2025. Bibliometrix/Biblioshiny and VOSviewer were used to evaluate scientific production, citation patterns, leading contributors, collaboration networks, and conceptual and thematic development. A total of 862 publications were analyzed, with scientific output accelerating markedly after 2019 and reaching its highest level in 2025. Thailand emerged as the dominant regional contributor, with Vongkamjan (n = 21) and Surachat (n = 20) as the two most prolific authors. Mahidol University (n = 182), Prince of Songkla University (n = 142), and Universiti Putra Malaysia (n = 139) were the leading institutions, demonstrating a concentration of research capacity in Thailand and Malaysia. Scientific Reports was the most productive journal (30 publications), whereas Frontiers in Microbiology recorded the highest citation count among the leading sources (963 citations). Collaboration mapping revealed increasingly interconnected regional and international research networks. Thematic analyses demonstrated a transition from foundational and pathogen-specific investigations toward AMR, bacteriophage therapy, biofilm control, aquaculture, genomic and comparative genomic analysis, wastewater and public-health applications, and One Health-oriented research. Emerging topics included endolysins, quorum sensing, CRISPR-associated approaches, metagenomics, and genome-informed phage characterization. These findings demonstrate the rapid expansion and thematic diversification of bacteriophage-based antimicrobial research in Southeast Asia while highlighting persistent geographic concentration and the need for stronger regional infrastructure, collaboration, and translational capacity.

8 July 2026 in Biology
Verified
Journal Article
Open access
PDF file
COChristian Joseph Ong
Christian Joseph Ong
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
EREdison D. Ramos
Edison D. Ramos
JMJoel G. Matamis
Joel G. Matamis
RDRich Milton Ramirez Dulay
Rich Milton Ramirez Dulay
Ganoderma lucidum (Lingzhi or Reishi) is among the most extensively studied medicinal mushrooms globally, owing to its diverse bioactive compounds and broad pharmacological properties. A scientometric analysis using the Scopus database was conducted to investigate global research trends on the bioactivity of G. lucidum. Bibliometric indicators, collaboration networks, keyword co-occurrence, thematic evolution, conceptual structure mapping, and life cycle modeling were assessed using Bibliometrix/Biblioshiny and VOSviewer version 1.6.20. A total of 2877 publications were included in the analysis. Scientific output increased markedly after 2010, peaking in 2025, indicating sustained growth in the field. China was identified as the leading contributor in terms of publication volume, influential authors, and prominent institutions, while international collaboration networks showed expanding global participation. Keyword and thematic analyses demonstrated a shift from early research focused on bioactivity screening, polysaccharides, and cultivation to mechanistic and translational investigations involving apoptosis, oxidative stress, immunomodulation, metabolomics, gut microbiota, network pharmacology, and disease-specific applications. Life cycle analysis suggested that the field is still in a rapid growth phase and has not yet reached saturation. Research on G. lucidum has evolved into a mature and highly interdisciplinary field, characterized by increasing scientific productivity, expanding international collaboration, and a growing emphasis on mechanistic and translational studies.